Czech and Slovak Ophthalmology 128 10.31348/2019/4/6 Case report Lichen Planus as a Possible Rare Cause of an Ocular Disease Nekolová Jana Středová Markéta Podhola Miroslav Jirásková Naďa 6 1 2020 4 6

Lichen planus is a relatively common mucocutaneous papulosquamous disorder of unknown etiology that is thought to be immunologically mediated. Ocular involvement of lichen planus (LP) is a rare event, which can lead to irreversible damage to the ocular surface and loss of vision from cicatrizing blepharoconjunctivitis and corneal scarring. Steroids are the first treatment choice. Treatment with topical ciclosporin A is also a possible treatment. We report a case of 79-year-old woman who was treated for long lasting severe inflammatory disease of a ocular surface. It led to blindness of one eye and low vision of the second eye. The diagnosis was made thanks to correlation of biopsy results from oral and ocular surface. The patient was also diagnosed with middle-stage dementia. Negative impact of steroid therapy on mental condition of this patient was considered. On the other hand, dementia could cause worse compliance with recommended treatment regime. Chronic inflammatory disease of ocular surface requires long lasting treatment very often and it is sometimes not as effective as expected. Discovering etiological causes of the disease is a priority for the right treatment. We emphasize also the key role of physical and mental condition in management of ocular surface disease.

 lichen planus cicatrizing blepharoconjunctivitis steroid therapy References Cipriani, G., Picchi, L., Vedovello, M., et al.: Reversible dementia from corticosteroid therapy. Case report. Clin Geriatrics, 20(7); 2012: 2-5. Dart, JK.: The 2016 Bowman lecture conjuntival curses: scarring conjunctivitis 30 years on. Eye, 31; 2017: 301-332. Dřízhal, I., Paulusová, V.: Orální lichen planus-současné po - znatky. Cesk Stomatol, 108(2); 2008: 35-38. Duchková, H.: Lichen planus. Doporučené postupy pro prak - tické lékaře. Dostupný na: www.cls.cz/dp. Reg. č. a/004/238. Elder, MJ., Bernauer, W., Leonard, J., et al.: Progression of disease in ocular pemphigoid. Br J Ophthalmol, 80; 1996: 292-6. Huang, S., Channa, P.: Cicatrical keratoconjunctivitis asso - ciated with lichen planus. A case report. GMS Ophthalmol Cases, 7(5); 2015:1-3. Igra, E., Kennedy, S., MacDermott, EJ. et al.: Isolated ocular lichen planus in a child. J AAPOS, 19(4); 2015: 381-3. Keenan, PA., Jacobson, MW., Soleymani, RM., et al.: The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology, 47(6); 1996: 1396-402. Muňoz, ER., Martínez-Escala, ME., Juanpere, N. et al.: Isolated conjunctival lichen planus. A diagnostic Challenge. Arch Dermatol, 147(4); 2011: 465-67. Pakravan, M., Klesert, TR., Akpek, EK.: Isolated lichen pla - nus of the conjunctiva. Br J Ophthalmol, 90(10); 2006: 1325- 6. Sacks, O., Shulman, M.: Steroid dementia: an overlooked diagnosis?. Neurology, 64(4); 2005: 707-9. Saw, VP., Dart, JK.: Ocular musous membrane pemphigoid: diagnosis and management strategies. Ocul Surf, 6(3); 2008: 128-42. Shoughy, SS.: Unusal ocular presentation in a patient with lichen planus. Can J Ophthalmol, 53; 2018: e122-24. Szabó, E., Palos, M., Skalická, P.: Oční jizevnatý pemfigoidrestrospektivní studie. Cesk Slov Oftalmol, 72 (1); 2016: 283-91. Thorne, JE., Jabs, DA., Nikolskaia, OV. et al.: Lichen planus and cicatrizing conjunctivitis: characterization of five cases. Am J Ophthalmol, 136(2); 2003: 239-43. Thorne, JE., Woreta, FA., Jabs, DA., et al.: Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy. Ophthalmology, 115(12); 2008: 2146-52. Viktorinová, M.: Nežádoucí účinky léků na kůži. Prakt. lékáren, 9(6); 2013: 214–18.